Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 60 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Symptom-based adjustment Clear all

Conditions: Obesity, Overweight, Healthy
Interventions: PF-04620110, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Bipolar Disorder
Interventions: JNJ-18038683, Placebo; Drug
Lead sponsor: Herbert Meltzer; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Anorexia Nervosa
Interventions: Quetiapine, Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Lung Cancer, Small Cell, Lung Cancer Metastatic, Lung Cancer Recurrent, Treatment Side Effects, Lung Cancer, Non-small Cell, Nutritional Imbalance
Interventions: Nutritional Counseling, Medically Tailored Meals (MTMs), Nutrition Prescription, Nutrition Assessment, Nutrition Toolkit, Monthly Emails; Behavioral · Other
Lead sponsor: Tufts University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 299 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 4
States / cities: Boston, Massachusetts • Columbus, Ohio • Philadelphia, Pennsylvania + 1 more

Conditions: Post Traumatic Stress Disorder, Opioid-use Disorder
Interventions: Lofexidine, Placebo oral tablet; Drug
Lead sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance; Other
Eligibility: 18 Years to 70 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Houston, Texas • San Antonio, Texas

Conditions: Heart Failure (HF)
Interventions: Ivabradine; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: Wilmington, Delaware • Detroit, Michigan • Buffalo, New York

Conditions: Paternal Postpartum Depression, Postpartum Anxiety
Interventions: Together in Parenting; Behavioral
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Toileting Disability, Functional Urinary Incontinence
Interventions: Defeating Urinary Incontinence with Exercise Training; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 60 Years and older · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: HIV Infections, Opioid Use, Trauma, Psychological
Interventions: Expressive Writing, Contingency Management; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 219 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Opioid Use Disorder
Interventions: buprenorphine/naloxone, Pharmacist-administered buprenorphine/naloxone maintenance care; Drug · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 6
States / cities: Durham, North Carolina • Raleigh, North Carolina

Conditions: Young Onset Dementia
Interventions: Resilient Together-YOD, Health Enhancement Program-YOD; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 388 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypochondriasis
Interventions: Fluoxetine, Cognitive Behavioral Therapy (CBT), Supportive Therapy, Placebo; Drug · Behavioral · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Boston, Massachusetts • New York, New York

Conditions: Anxiety, Depression, Epilepsy
Interventions: Escitalopram 10mg; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Spinocerebellar Ataxia (SCA), Spinocerebellar Ataxia Type 6
Interventions: Deep Brain Stimulation; Device
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 89 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Heart Failure, Systolic, Depression, Cardiovascular Disease
Interventions: Collaborative Care for Heart Failure, Collaborative Care for Depression; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years and older
Enrollment: 756 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Asthma
Interventions: Terbutaline; Drug
Lead sponsor: Kanecia Obie Zimmerman; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Aurora, Colorado • Burlington, Vermont

Conditions: Smoking Cessation
Interventions: Group Cognitive Behavioral Therapy, General Health Education, Transdermal Nicotine Patch; Behavioral · Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 356 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Coral Gables, Florida • Tampa, Florida

Conditions: Pancreatic Cancer
Interventions: Quality fo Life Questionnaire (FHSI), Vioscreen Food Frequency Questionnaire (FFQ), Educational Handouts, NutritionCoaching, Follow-Up Survey, Functional Assessment of Anorexia/Cachexia Treatment (FAACT) Questionnaire, Patient Reported Outcomes Measure- Cognitive Function (PROMIS-Cog) Questionnaire; Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Autosomal Dominant Polycystic Kidney Disease
Interventions: Mayo Clinic-Approved Education, Digital Neuropathy, Capacity Coaching; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Asthma
Interventions: Asthma controller medication (Beclomethasone) adjustment strategy, Provider-based adjustment; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 6 Years to 17 Years
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Anxiety, Depression, Epilepsy
Interventions: Escitalopram 10mg, Referral to Psychiatry, Survey only; Drug · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Low Risk Acute Coronary Syndrome
Interventions: Stress Test, No Stress Test; Procedure
Lead sponsor: University of Oklahoma; Other
Eligibility: 30 Years to 75 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Multiple Sclerosis
Interventions: Inspiratory Muscle Trainer (IMT); Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Boston, Massachusetts • Flint, Michigan

Conditions: Mild Traumatic Brain Injury
Interventions: Sub-symptomatic Adaptable Exercise Treatment (SAET), Stretching Control Group (SCG); Behavioral
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Camp Pendleton, California

Search by objective public record fields.

A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers

Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients

Trial of Quetiapine in Anorexia Nervosa

NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer

Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans

A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.

Feasibility and Acceptability of a Novel Digital Intervention For Perinatal Men Who Have Depression or Anxiety

Defeating Urinary Incontinence With Exercise Training (DUET) Feasibility Study

Trauma Intervention to Optimize PrEP Among Women Who Inject Drugs

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075

Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners

Treatment of Hypochondriasis With CBT and/or SSRI

Anxiety and Depression in Epilepsy: A Pilot Treatment Study

Interposed Nucleus aDBS for Ataxia

Blended Collaborative Care for Heart Failure and Co-Morbid Depression

Terbutaline Sulfate in Adults With Asthma

Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention

The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response

Managing Depressive Symptoms in ADPKD

Asthma Symptom Based Adjustment of Inhaled Steroid Therapy in African American Children

Anxiety and Depression in Epilepsy: A Treatment Study

Low Risk Acute Coronary Syndrome

Effects of Inspiratory Muscle Training in Persons With Advanced Multiple Sclerosis

Treatment Optimization of Brain-injured Warfighters